
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
Most Trending
30 Dec 2025$AFRM Affirm remains firmly in favor with Bank of America maintaining its Buy rating despite a marginal trim to the price target. The adjustment reflects pre-quiet period estimate tweaks rather than a shift in conviction. For traders, AFRM continues to represent exposure to the digital payments theme, with sentiment supported by its positioning among top fintech growth names even as valuation sensitivity stays high.
$BK Bank of New York Mellon holding a Buy rating after a massive rally speaks to confidence in its earnings durability and balance sheet strength. A 115% run naturally raises questions about upside compression, but analysts sticking with a constructive stance suggest the underlying business momentum and capital return story remain intact for near-term positioning.
$CRBG Corebridge Financial is drawing increasing bullish attention as a value reopening play. With roughly 70% of analysts rating it a Buy and a median target implying close to 30% upside, CRBG stands out as a fundamentally cheap financial name where improving sentiment could act as a catalyst for traders hunting re-rating opportunities.
$ERO Ero Copper entered the upgrade conversation via a fresh Buy initiation with a $32 target, pointing to confidence in copper leverage and operational execution. With shares trading below that level, the stock offers a clear risk-reward setup tied to commodity momentum and analyst coverage expansion.
$ETSY Etsy Buy reiteration comes alongside a reduced price target, signaling cautious optimism rather than outright enthusiasm. The market appears to be waiting for clearer evidence that evolving strategy can offset competitive and consumer headwinds, making ETSY more of a selective trade than a momentum upgrade.
$META Meta Platforms continues to command Buy ratings even after slight target trims. Analysts remain focused on its long-term wealth-creation potential, particularly around AI, advertising efficiency, and scale advantages. For traders, META represents a high-confidence large-cap upgrade where pullbacks are still viewed as opportunities.
$MRK Merck reaffirmed Buy rating highlights its appeal as an affordable healthcare leader with both defensive and growth attributes. A solid pipeline and strategic alignment with policy developments underpin confidence, positioning MRK as a steadier upgrade candidate amid market volatility.
$PFE Pfizer sees mixed analyst views, but the reiterated Buy and defined $30 target reinforce its value appeal. With sentiment already compressed, PFE offers traders a contrarian healthcare upgrade angle where downside appears increasingly priced in.
$PYPL PayPal is the outlier in the list, with Morgan Stanley cutting both its rating and target. While still cited among leading digital payments names, this shift introduces near-term pressure rather than upside, making PYPL more of a cautionary contrast to the day upgrades.
$QSR Restaurant Brands’ upgrade to a Buy reflects improving earnings optimism and operational momentum. As a consumer discretionary name with visible catalysts, QSR could attract traders looking for follow-through after analyst confidence turns positive.
$SBFG SB Financial Group upgrade to Strong Buy signals strong earnings trajectory expectations. Smaller financials often react sharply to such rating changes, making SBFG a potential short-term momentum play for traders focused on Zacks-driven upgrades.
$SNY Sanofi maintaining a Buy rating despite regulatory overhang underscores analyst confidence in valuation and long-term fundamentals. The "cheap" label and steady outlook may appeal to traders favoring asymmetric setups where bad news is already discounted.
$TEVA Teva benefits from a credit rating upgrade, reinforcing improving financial stability. While not a traditional equity analyst upgrade, the positive signal supports confidence in balance sheet repair, which can translate into renewed equity interest in the near term.
$TFC Despite the ticker label, the bullish narrative centers on Broadcom, where Buy reiterations persist even after a strong year-to-date run. Analysts still see meaningful upside, reinforcing the idea that leadership semiconductor names remain favored upgrade beneficiaries.
$VALE Vale addition to the Strong Buy list highlights renewed optimism in materials and commodities. For traders, VALE offers leveraged exposure to global demand dynamics with analyst support acting as a short-term tailwind.
08:37 PM
08:30 PM
01:23 PM
01:08 PM
09:32 AM
Yesterday at 08:44
Yesterday at 08:36
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
08:37 PM
08:30 PM
01:23 PM
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.